Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Blood
|
December 13, 2019
The earlier the better: timely mitigation of CRS
Rayne H Rouce
Nature Reviews. Immunology
|
September 22, 2025
Clearing the hurdles for CAR-T cell treatment
Rayne H Rouce
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2015
More than Memory: Potential of Adaptive Natural Killer Cells
Rayne H Rouce
Blood
|
August 14, 2025
Rest, then rejuvenate: CD19 boost to improve CAR persistence
Rayne H Rouce
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 22, 2025
Conquering the gene and cell therapy viability crisis: A path paved by ASGCT
Rayne H Rouce
Blood
|
August 4, 2022
Reverse translational studies inform dual-targeted CAR T-cell design
Rayne H Rouce, Lauren Scherer
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2018
Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML
Erin Doherty, Rayne H Rouce
The Journal of Clinical Investigation
|
April 16, 2019
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine
Sandhya Sharma, Rayne H Rouce
Frontiers in Immunology
|
December 5, 2015
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani, Rayne H Rouce
Blood
|
February 9, 2023
Access offsets poverty in quest for CAR T cells
Rayne H Rouce, Eneida Nemecek
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Blood
|
December 13, 2019
The earlier the better: timely mitigation of CRS
Rayne H Rouce
Nature Reviews. Immunology
|
September 22, 2025
Clearing the hurdles for CAR-T cell treatment
Rayne H Rouce
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2015
More than Memory: Potential of Adaptive Natural Killer Cells
Rayne H Rouce
Blood
|
August 14, 2025
Rest, then rejuvenate: CD19 boost to improve CAR persistence
Rayne H Rouce
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 22, 2025
Conquering the gene and cell therapy viability crisis: A path paved by ASGCT
Rayne H Rouce
Blood
|
August 4, 2022
Reverse translational studies inform dual-targeted CAR T-cell design
Rayne H Rouce, Lauren Scherer
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2018
Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML
Erin Doherty, Rayne H Rouce
The Journal of Clinical Investigation
|
April 16, 2019
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine
Sandhya Sharma, Rayne H Rouce
Frontiers in Immunology
|
December 5, 2015
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani, Rayne H Rouce
Blood
|
February 9, 2023
Access offsets poverty in quest for CAR T cells
Rayne H Rouce, Eneida Nemecek
Page
of 6